Nasdaq
$4.97▲ 4.63%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $7.3MShares out 1.5M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
8- 10.2Pre-market26.10.02 21:008-KKey event#●●●
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals held its 2026 Annual Meeting of Stockholders on September 30, 2026, where shareholders approved amendments to the 2020 Equity Plan. The amendment increases the number of shares authorized for issuance under the plan by 650,000, bringing the total to 765,061 shares.…more
$4.97+4.63%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.25After-hours26.08.26 06:23DEFA14AOther
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals will hold its 2026 Annual Meeting of Stockholders on September 30, 2026, at 12:00 PM EST. Key proposals include the election of directors, ratification of MaloneBailey, LLP as the independent accounting firm, advisory approval of executive compensation, and an amendment to the 2020 Stock Plan to increase authorized shares by 650,000.…more
$4.97+4.63%vs prev closeView filingShare - 8.21After-hours26.08.22 06:15DEF 14AOther
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals will hold its 2026 Annual Meeting of Stockholders on September 30, 2026, to vote on the election of directors, appointment of auditors, executive compensation, and an increase of 650,000 shares to the 2020 Stock Plan. Shareholders of record as of August 10, 2026, are eligible to vote, and the proposed increase in authorized shares for the stock plan will result in dilution for existing shareholders.…more
$4.97+4.63%vs prev closeView filingShare
7 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswireNo news collected yet. New articles will appear here.